Brief: Corline Biomedical Q4 Net Sales SEK 2.1 Mln
Feb 17 (Reuters) - Corline Biomedical AB CLBIO.ST: Q4 2025 NET SALES 2,104 KSEK Q4 RESULT AFTER FINANCIAL ITEMS AMOUNTED TO SEK -5,027 THOUSAND (-14,161) Source text: ID:nGNE114pQn Further company coverage: CLBIO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln